SINTX Technologies Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY
June 30 2021 - 9:00AM
SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or
the “Company”), an original equipment manufacturer of silicon
nitride ceramic for medical and non-medical applications, announced
today it has moved into the next phase of its relationship with
O2TODAY and sold the first shipment of FleX SN-AP antipathogenic
silicon nitride powder to O2TODAY for integration into a
proprietary line of masks and filters.
“O2TODAY announced on its website today that it
is taking limited pre-orders for masks and mask filters integrated
with SINTX’s antipathogenic powder,” said Dr. Sonny Bal, President
and CEO at SINTX Technologies. “We share the excitement at this
development, and we’ve appreciated the opportunity to collaborate
on the development of O2TODAY’s products over the past year.”
SINTX is the supplier of FleX SN-AP
antipathogenic silicon nitride powder to O2TODAY. The powder is
used to make O2TODAY’s face masks and mask filters which were
developed during a collaboration entered by the two companies in
the midst of the 2020 COVID-19 pandemic. That collaboration has led
to several milestones including a 2-year Technology License
Agreement with a fee for the exclusive use of SINTX’s technology in
face masks and mask filters, a commercial agreement on silicon
nitride sales, and royalties from product sales.
SINTX continues to work with other partners to
develop products with its FleX SN-AP powder. SINTX’s FleX SN-AP can
rapidly inactivate a wide range of bacteria, molds, and viruses,
including SARS-CoV-2, Influenza A, and H1N1. FleX SN-AP can be
incorporated into many consumer products and touch surfaces, making
them resistant to disease-causing microbes. The SINTX R&D team
has the knowledge and expertise to create niche applications with
FleX SN-AP technology to enhance your company’s products.
O2TODAY’s masks and filters with silicon nitride
are expected to become available for limited pre-orders starting on
July 6, 2021. For more information please
visit https://o2today.com/products/sinpro
or direct inquiries
to info@o2today.com.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company
that develops and commercializes silicon nitride for medical and
non-medical applications. The core strength of SINTX Technologies
is the manufacturing, research, and development of silicon nitride
ceramics for external partners. The Company presently manufactures
silicon nitride powders and components in its FDA registered, ISO
13485:2016 certified, and ASD9100D certified manufacturing
facility.
For more information on SINTX Technologies or its silicon
nitride material platform, please visit www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (PSLRA) that are subject to a number of risks
and uncertainties. Risks and uncertainties that may cause such
differences include, among other things: that O2TODAY will be able
to manufacture a face mask incorporating FleX SN-AP antipathogenic
silicon nitride powder and that it will be able to manufacture such
face marks in commercial quantities; demand for O2TODAY’S face mask
is uncertain and it may not be able to manufacture at a cost that
is competitive with other face masks; no assurance can be given the
O2TODAY mask and filters will become available for limited
pre-orders starting July 6, 2021; volatility in the price of
SINTX’s common stock; the uncertainties inherent in new product
development, including the cost and time required to commercialize
such product(s); market acceptance of our products once
commercialized; SINTX’s ability to raise funding and other
competitive developments. Readers are cautioned not to place undue
reliance on the forward-looking statements, which speak only as of
the date on which they are made and reflect management’s current
estimates, projections, expectations and beliefs. There can be no
assurance that any of the anticipated results will occur on a
timely basis or at all due to certain risks and uncertainties, a
discussion of which can be found in SINTX’s Risk Factors disclosure
in its Annual Report on Form 10-K, filed with the Securities and
Exchange Commission (SEC) on March 22, 2021, and in SINTX’s other
filings with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
Business Inquiries for
SINTX:SINTX Technologies801.839.3502IR@sintx.com
Media Inquiries for SINTX:
Amanda Barry Director of PR and ContentThe Summit Group
abarry@summitslc.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Aug 2024 to Sep 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Sep 2023 to Sep 2024